Back to MW MARSHALL WACE, LLP

PLXPLX
9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PROTALIX BIOTHERAPEUTICS INC

MARSHALL WACE, LLP holds 452,757 shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $1.1M as of 2026-Q2. This is a new position. PLX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1.1M

Current Shares

452,757

Total Value Change

+$739,172

Total Shares Change

+302,399

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
452,757
-
$1.1M0.0%$2.33
35
2026-Q1
Exited
0
-100.0%
$00.0%$2.83
0
2025-Q4
New
19,079
-
$34,3420.0%$1.74
30
2025-Q2
Exited
0
-100.0%
$00.0%$1.54
0
2025-Q1
Increased
615,085
+503.6%
$1.6M0.0%$2.58
41
2024-Q4
New
101,899
-
$191,5700.0%$1.89
31
2023-Q3
Exited
0
-100.0%
$00.0%$1.66
0
2023-Q2
Increased
562,139
+273.9%
$1.1M0.0%$2.17
41
2023-Q1
New
150,358
-
$315,7530.0%$2.02
33

Other major holders of PLX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used